Nike Is Suing Lululemon Over Patent Infringement, Again: Here’s What Investors Need To Know About The War Between These Athletic Apparel Giants Forbes – Markets

February 6, 2023

A+ A-

Email Print

Nike Is Suing Lululemon Over Patent Infringement, Again: Here’s What Investors Need To Know About The War Between These Athletic Apparel Giants Forbes – Markets

Nike utilizes the court system frequently, and its latest case is against Lululemon. This marks the second IP case between the two giants in just one year.

Commercial Stage Biotech. One press release away from becoming a triple digit gainer! March 27, 2023
Hello everyone and welcome to all our new members, Commercial Stage Biotech One big press release away from becoming a triple digit gainer! Diagnostics biotech company with multiple near-term catalysts, small float, great news just released and recent analyst coverage indicating over 120% upside (See Analyst Reports Below). This one has demonstrated the ability to run up
Three Very Promising Biotech Stocks to Watch in 2023 March 27, 2023
In 2022, the biotech industry faced a challenging year due to profit-taking, clinical setbacks, stricter FDA regulations, geopolitical unrest, rising interest rates, and risk aversion. The SPDR S&P Biotech ETF plummeted by 53%, which led to a mass exodus of capital from the biotech space, and the once-sizzling IPO market in biotech has suddenly gone
Traders News Source Breaks Down the Best AI and Quantum Computing ETF’s and Their Holdings March 5, 2023
Right now, two of the hottest sectors are AI and Quantum Computing Traders News Source Breaks Down the Best AI and Quantum Computing ETF’s and Their Holdings You probably interact with artificial intelligence (AI) more often than you think. It’s the algorithm arranging your Netflix (NASDAQ:NFLX) menu, the software expediting your Amazon (NASDAQ:AMZN) package, and

Newer PostWhat Companies Are Fueling The Progress In Natural Language Processing? Moving This Branch Of AI Past Translators And Speech-To-Text Forbes – Markets

Older PostRussian Aluminum Tariffs Mostly Good For Speculators, Not Much Else Forbes – Markets

Scroll

Like to share?